BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7684796)

  • 1. Apoptosis induction in CD5+(Ly1+) malignant B cells.
    Peng B; Raveche E
    Leukemia; 1993 Jun; 7(6):789-94. PubMed ID: 7684796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cultured malignant B-1 line serves as a model for Richter's syndrome.
    Peng B; Sherr DH; Mahboudi F; Hardin J; Wu YH; Sharer L; Raveché ES
    J Immunol; 1994 Aug; 153(4):1869-80. PubMed ID: 8046247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered response to and production of TGF-beta by B cells from autoimmune NZB mice.
    Douglas RS; Woo EY; Capocasale RJ; Tarshis AD; Nowell PC; Moore JS
    Cell Immunol; 1997 Aug; 179(2):126-37. PubMed ID: 9268496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NZB mouse as a model for chronic lymphocytic leukemia.
    Phillips JA; Mehta K; Fernandez C; Raveché ES
    Cancer Res; 1992 Jan; 52(2):437-43. PubMed ID: 1370214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of IL-2 hyper-responsive NZB/WF1 CD5- B cells.
    Hirose S; Nakanishi K; Yoshimoto T; Kashiwamura S; Hiroishi K; Matsumoto H; Hamaoka T; Shinka S; Higashino K
    J Immunol; 1994 Aug; 153(4):1847-57. PubMed ID: 7519217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major histocompatibility complex controls clonal proliferation of CD5+ B cells in H-2-congenic New Zealand mice: a model for B cell chronic lymphocytic leukemia and autoimmune disease.
    Okada T; Takiura F; Tokushige K; Nozawa S; Kiyosawa T; Nakauchi H; Hirose S; Shirai T
    Eur J Immunol; 1991 Nov; 21(11):2743-8. PubMed ID: 1718758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of differentiation in CD5+ and conventional B cells. Sensitivity to LPS-induced differentiation and interferon-gamma-mediated inhibition of differentiation.
    Chace JH; Abed NS; Adel GL; Cowdery JS
    Clin Immunol Immunopathol; 1993 Sep; 68(3):327-32. PubMed ID: 7690316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperdiploid-CD5-positive B cells in mouse.
    Raveche ES; Tjio JH
    Int J Hematol; 1991 Feb; 54(1):25-35. PubMed ID: 1954348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell-independent and T cell-dependent B cell activation increases IFN-gamma R expression and renders B cells sensitive to IFN-gamma-mediated inhibition.
    Abed NS; Chace JH; Cowdery JS
    J Immunol; 1994 Oct; 153(8):3369-77. PubMed ID: 7523492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of differentiation in a B lymphoma X B lymphocyte hybrid line. II. Intraclonal heterogeneity in growth, secretion of IgM, and cytokine production in response to lipopolysaccharide.
    Little J; Alling DW; Asofsky R
    J Immunol; 1993 Mar; 150(6):2129-38. PubMed ID: 8450206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulatory capability of murine CLL-like CD5+ B cells.
    Phillips J; Raveché E
    Ann N Y Acad Sci; 1992 May; 651():488-90. PubMed ID: 1376068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of host environment on growth of clonal CD5+B (Lyl+B) cells.
    Raveche ES; Lin TZ; Conroy J; Tjio JH; Steinberg AD; Rudolfsky UA; Phillips JA
    Autoimmunity; 1991; 10(3):217-25. PubMed ID: 1721848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal IgM rheumatoid factor secreted by CD5-negative B cells during mixed cryoglobulinemia. Evidence for somatic mutations and intraclonal diversity of the expressed VH region gene.
    Crouzier R; Martin T; Pasquali JL
    J Immunol; 1995 Jan; 154(1):413-21. PubMed ID: 7527818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resting B cells from New Zealand Black mice demonstrate a defect in apoptosis induction following surface IgM ligation.
    Kozono Y; Kotzin BL; Holers VM
    J Immunol; 1996 Jun; 156(11):4498-503. PubMed ID: 8666826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of differentiation of peritoneal B-1a (CD5+) B cells. Activated peritoneal macrophages release prostaglandin E2, which inhibits IgM secretion by peritoneal B-1a cells.
    Chace JH; Fleming AL; Gordon JA; Perandones CE; Cowdery JS
    J Immunol; 1995 Jun; 154(11):5630-6. PubMed ID: 7538527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered CD45 expression in malignant B-1 cells.
    Dang AM; Phillips JA; Lin T; Raveche ES
    Cell Immunol; 1996 May; 169(2):196-207. PubMed ID: 8620547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective antigen-receptor-mediated regulation of immunoglobulin production in B cells from autoimmune strains of mice.
    Anderson CC; Cairns E; Rudofsky UH; Sinclair NR
    Cell Immunol; 1995 Aug; 164(1):141-9. PubMed ID: 7634346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for differential responsiveness of human CD5+ and CD5- B cell subsets to T cell-independent mitogens.
    Zupo S; Dono M; Azzoni L; Chiorazzi N; Ferrarini M
    Eur J Immunol; 1991 Feb; 21(2):351-9. PubMed ID: 1705511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli.
    Jongstra-Bilen J; Vukusic B; Boras K; Wither JE
    J Immunol; 1997 Dec; 159(12):5810-20. PubMed ID: 9550377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological characterization of mouse B-1 cells.
    Abrahão TB; Freymüller E; Mortara RA; Lopes JD; Mariano M
    Immunobiology; 2003; 208(4):401-11. PubMed ID: 14748513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.